Latest results of Phase 2 study confirm high rate of response, remission
–University of Texas M. D. Anderson Cancer Center|2013-06-19
–Society of Gynecologic Oncology|2013-06-19
Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic interaction between single nucleotide polymorphisms (SNPs). The goal is to better predict a prostate cancer’s aggressiveness to avoid unnecessary radical treatment.
–Moffitt Cancer Center |2013-06-19
Highly sensitive and accurate test detects cancer-related microRNA in blood of patients even before the development of colorectal cancer.
–Baylor Health Care System|2013-06-19
Signal tells MCM7 to launch DNA replication; pathway reduces breast cancer patient survival
–University of Texas M. D. Anderson Cancer Center|2013-06-18
Local chemical signals released by fat cells in the mammary gland appear to provide a crucial link between exposure to unrelenting social stressors early in life, and the subsequent development of aggressive breast cancer.
–University of Chicago Medical Center|2013-06-18
A recently published paper by the George Washington University Cancer Institute addresses the value of patient navigation programs for community cancer centers.
–George Washington University|2013-06-18
Dana-Farber researchers find many men with low-risk, localized prostate cancers can safely choose observation instead of undergoing immediate treatment and a have better quality of life while reducing health care costs.
–Dana-Farber Cancer Institute|2013-06-18
Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells in at least one pre-cancerous condition.
–University of California, San Francisco (UCSF)|2013-06-17
Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils.
–National Cancer Institute (NCI) at NIH|2013-06-17
A new drug called pyrvinium pamoate inhibits aggressive forms of prostate cancer that are resistant to standard drugs, according to a study conducted in an animal model. The results will be presented Monday at The Endocrine Society’s 95th Annual Meeting in San Francisco.
A study by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences and the Department of Pharmacology at the University of California, San Diego, shows that a protein called MCL-1, which promotes cell survival, is essential for normal heart function.
–University of California, San Diego Health Sciences|2013-06-17
Ubiquitous plasticizers may have long-term health effects.
–University of Illinois at Chicago|2013-06-17
Exposing developing tissue to low levels of the plastic bisphenol A, commonly known as BPA, is linked to a greater incidence of prostate cancer in tissue grown from human prostate stem cells, a new study finds. The results will be presented Monday, June 17, at The Endocrine Society’s 95th Annual Meeting in San Francisco.
A new molecular pathway involving the gene ZNF365 has been identified and abnormalities in that pathway may predict worse outcomes for patients with breast cancer, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.
–American Association for Cancer Research (AACR)|2013-06-17
Researchers have discovered a molecular switch that explains, at least in part, how some fast-growing prostate cancers become resistant to hormone treatment, a new study conducted in human cell cultures and mice finds. The results were presented Saturday at The Endocrine Society’s 95th Annual Meeting in San Francisco.
A new osteoporosis drug hinders the growth of estrogen-sensitive cancer that has become resistant to treatment with tamoxifen, a study in mice shows.
A new genetic test accurately and consistently diagnoses benign growths, or nodules, on the thyroid gland, according to a study from Chile.
A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer Institute study.